Results 81 to 90 of about 6,025 (196)

Intravenous tenecteplase compared with alteplase for minor ischaemic stroke: a secondary analysis of the AcT randomised clinical trial

open access: yesStroke and Vascular Neurology
Background In ischaemic stroke, minor deficits (National Institutes of Health Stroke Scale (NIHSS) ≤5) at presentation are common but often progress, leaving patients with significant disability.
Dar Dowlatshahi   +28 more
doaj   +1 more source

Estudo da associação entre a ativação da resposta inflamatória sistêmica na fase aguda do infarto do miocárdio com supradesnivelamento do segmento ST e a zona peri-infarto, definida por ressonância magnética [PDF]

open access: yes, 2013
Tese (doutorado)—Universidade de Brasília, Faculdade de Medicina, Programa de Pós-Graduação em Ciências Médicas, 2013.Introdução: O aumento da atividade inflamatória sistêmica (AIS) durante o infarto domiocárdio (IM) está diretamente associado à ...
Silva, José Carlos Quinaglia e
core  

Concomitant pulmonary embolism and aortic dissection: approach to anticoagulation [PDF]

open access: yes, 2018
Os autores descrevem um caso de uma doente admitida após episódio pré-sincopal associado a precordialgia e cujo ecocardiograma sumário feito no Servic¸o de Urgência demonstrou alterac¸ões compatíveis com tromboembolismo pulmonar, tendo a doente sido ...
Augusto, J   +6 more
core   +1 more source

Risk of angioedema and thrombolytic therapy among stroke patients: An analysis of data from the FDA Adverse Event Reporting System database

open access: yesNeurotherapeutics
The angioedema risk may vary among stroke patients receiving different thrombolytic agents. This study aimed to investigate the angioedema risk associated with different thrombolytic agents and to identify associated risk factors.
Hunong Xiang   +8 more
doaj   +1 more source

Ethnic Differences in the Safety and Efficacy of Tenecteplase Versus Alteplase for Acute Ischemic Stroke: A Systematic Review and Meta-Analysis [PDF]

open access: yesJournal of Stroke
Background and Purpose Tenecteplase is a thrombolytic agent with pharmacological advantages over alteplase and has been shown to be noninferior to alteplase for acute ischemic stroke in randomized trials.
Jin Hean Koh   +10 more
doaj   +1 more source

Uso de trombolíticos e associações farmacológicas no tratamento do acidente vascular cerebral isquêmico agudo : revisão sistemática e meta-análise em rede [PDF]

open access: yes, 2017
Dissertação (mestrado)—Universidade de Brasília, Faculdade de Ciências da Saúde, Programa de Pós-Graduação em Ciências da Saúde, 2017.Introdução: O acidente vascular cerebral isquêmico (AVCi) é uma das principais causas de mortalidade e incapacidade ...
Brito, Gabriela Vilela de
core  

Randomized trial of inhaled nitric oxide to treat acute pulmonary embolism: The iNOPE trial [PDF]

open access: yes, 2017
BACKGROUND: The study hypothesis is that administration of inhaled nitric oxide (NO) plus oxygen to subjects with submassive pulmonary embolism (PE) will improve right ventricular (RV) systolic function and reduce RV strain and necrosis, while ...
Hall, Cassandra L.   +5 more
core   +1 more source

Spinal subdural hematoma as a complication of tenecteplase treatment for acute ischemic stroke: A case report

open access: yesHeliyon
Intravenous thrombolysis is an effective treatment for acute ischemic stroke. The ESO recommends that tenecteplase be used for thrombolytic therapy in stroke within 4.5h of onset.
Sisi Zhao   +3 more
doaj   +1 more source

Design of a recombinant tissue plasminogen activator production plant [PDF]

open access: yes, 2013
Conté: Part 1, General vision and presentation of the plant / Ferran Vila. Part 2, Technical characteristics of the process / Carla Sánchez.
Roca, Ramon   +3 more
core  

Comparison between zofenopril and ramipril in combination with acetylsalicylic acid in patients with left ventricular systolic dysfunction after acute myocardial infarction: results of a randomized, double-blind, parallel-group, multicenter, European study (SMILE-4) [PDF]

open access: yes, 2012
BACKGROUND: Angiotensin-converting enzyme inhibitors (ACEIs) are largely employed for treating patients with left ventricular dysfunction (LVD), but their efficacy may be negatively affected by concomitant administration of acetylsalicylic acid (ASA),
Claudio Borghi   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy